Moderna Stock Surges Over 10% Amid Bird-Flu Concerns
Moderna shares soar by more than 10% after the first U.S. bird-flu death. Discover how health crises impact biotech stocks.
Moderna shares jumped more than 10% following the first U.S. bird-flu death.